News Breaks |
|
|
| October 1, 2012 |
| 08:02 EDT |  | MDT | Medtronic shares should be bought at current levels, says Wells Fargo
After meeting with Medtronic's CFO, Wells Fargo believes that the consensus FY13 EPS estimate appears conservative and it maintains an Outperform rating on the stock. |
|
|
News For MDT From The Last 14 Days Check below for free stories on MDT the last two weeks. |
|
|
| May 16, 2013 |
| 13:32 EDT |  | MDT | Medtronic volatility flat into Q4 and outlook
 Subscribe for More Information |
|
| 10:03 EDT |  | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 06:32 EDT | | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| May 10, 2013 |
| 15:49 EDT |  | MDT | Medtronic defibrillators demonstrate success of shock avoidance
Subscribe for More Information |
|
| May 8, 2013 |
| 07:38 EDT |  | MDT | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 6, 2013 |
| 09:19 EDT | | MDT | Medtronic receives FDA approval for newest cardiac devices
Medtronic announced FDA approval and U.S. launch of its newest cardiac devices: the Viva portfolio of cardiac resynchronization therapy with defibrillation, or CRT-D, devices, and the Evera portfolio of implantable cardioverter-defibrillators. |
|
|
|
|
|
